Resources for observational comparative research have expanded enormously in recent years to include very large sources of ...

This is a paradigm shift in how we approach the most ‘untreatable’ cancers”— John Warlick, Founder of Immunosonics ...

Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary ...

Startup Forward Inc. today rolled out Forward Predict, software that lets customers model the impact of network changes ...

The deepest conference in the country has at least seven teams with legitimate College Football Playoff hopes heading into ...

The registrational intent ACR-368 Phase 2b study is advancing with a prespecified simultaneous interim analysis and data update for both ...

A study published in Engineering has demonstrated that the N-glycome of serum-derived extracellular vesicles (EVs) can serve ...

There's a version of Carson Beck's story that could've ended at Georgia, as the top quarterback selected in last year's NFL Draft had his junior season gone as planned in 2024. Af ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced that it has received a successful response to its recent Type C meeting request from the U.S ...

Researchers develop an interpretable hybrid feature selection model to overcome the "curse of dimensionality"in genomic ...

New York Giants head coach John Harbaugh believes his new team has the talent to compete immediately in 2026. That may well ...